Parmax Pharma Ltd.
Search Company
  You can view the Income statement for the last 5 years.
ISIN No INE240T01014 52Wk High (Rs.) 55 BV (Rs.) -7.21 FV (Rs.) 10.00
Bookclosure 30/09/2024 52Wk Low (Rs.) 28 EPS (Rs.) 0.00 P/E (X) 0.00
Mkt Cap. (Rs. Cr.) 13.09 P/BV (X) -4.85 Div Yield (%) 0.00 Mkt Lot 1
 
(Rs. in Crs.)
ParticularsDec 24Dec 23Dec 22Dec 21Dec 20
Net Sales/Income from operations23.386.809.0411.1618.81
Total Income From Operations23.386.809.0411.1618.81
      
EXPENDITURE     
Consumption of Raw Materials18.582.266.462.9510.26
Increase/Decrease in Stocks-0.751.52-4.570.00-0.81
Employees Cost2.412.412.202.982.90
Depreciation1.211.301.411.431.44
Other Expenses2.323.173.533.363.74
Total Expenses23.7710.679.0310.7217.52
      
P/L Before Other Inc. , Int., Excpt. Items & Tax-0.39-3.870.010.441.29
Other Income0.140.030.020.050.07
P/L Before Interest, Excpt. Items & Tax-0.25-3.840.040.491.36
Interest0.350.460.310.300.30
P/L Before Exceptional Items & Tax-0.60-4.30-0.280.191.06
P/L Before Tax-0.60-4.30-0.280.191.06
P/L After Tax from Ordinary Activities-0.60-4.30-0.280.191.06
Net Profit/Loss For the Period-0.60-4.30-0.280.191.06
      
Equity Share Capital3.743.743.743.743.74
EPS Before Extra Ordinary *     
Basic EPS (Rs.)-1.60-11.49-0.740.502.83
Diluted EPS (Rs.)-1.60-11.49-0.740.502.83
EPS After Extra Ordinary *     
Basic EPS (Rs.) -1.60-11.49-0.740.502.83
Diluted EPS (Rs.) -1.60-11.49-0.740.502.83
      
PBITOE Margin (%)-1.66-57.020.143.956.86
PBTE Margin (%)-2.56-63.27-3.061.675.62
PBT Margin (%)-2.56-63.27-3.061.675.62
PAT Margin (%)-2.56-63.27-3.061.675.62